TrippBio is a biotech company that offers discovery, synthesis, and commercialization services for novel antiviral drugs and treatments.
TrippBio has raised $185K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in November 2024.
TrippBio is headquartered in Jacksonville, United States.
TrippBio is a biotech company that offers discovery, synthesis, and commercialization services for novel antiviral drugs and treatments.
TrippBio is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TrippBio — Funding & Investors." VCBacked, November 15, 2024, https://www.vcbacked.co/company/trippbio. Accessed October 12, 2026.
VCBacked. (2024). TrippBio — Funding & Investors. Retrieved October 12, 2026, from https://www.vcbacked.co/company/trippbio
{{cite web |title=TrippBio — Funding & Investors |url=https://www.vcbacked.co/company/trippbio |website=VCBacked |access-date=October 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated